• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of orphan drug designation reviews completed in 90 days or less

Dictionary: OOPD will track the time it takes to complete the review of each Orphan Drug designation application. OOPD’s goal is to provide all applicants with a complete and comprehensive review in a timely manner by monitoring the incoming workload and allocating resources as needed. The target review percentages per the noted review periods will continue to ensure high quality service to OOPD orphan drug applicant customers.

Information is current as of June 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20137584
Nov 20137583
Dec 20137598
Jan 20147589
Feb 20147568
Mar 20147582
Apr 20147594
May 20147598
Jun 201475100
Jul 201475TBD
Aug 201475TBD
Sep 201475TBD

FY 2014 YTD: 89%

Total number of orphan drug designation reviews completed in 90 days or less

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber of Reviews
Oct 2013N/A43
Nov 2013N/A29
Dec 2013N/A39
Jan 2014N/A24
Feb 2014N/A28
Mar 2014N/A23
Apr 2014N/A48
May 2014N/A43
Jun 2014N/A43
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 320

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.